Last Update 25 Jun 26
SUMICHEM: Future View Will Favour Stable Payout And Undervalued Upside
Analysts have maintained their fair value estimate for Sumitomo Chemical India at ₹555.33 per share, with only minor technical adjustments to inputs such as the discount rate, long-term revenue growth, profit margin assumptions, and future P/E, none of which materially change the overall price target narrative.
What's in the News
- Sumitomo Chemical India scheduled a board meeting on May 26, 2026 to consider audited standalone and consolidated financial statements for the year ended March 31, 2026, and to review a potential dividend recommendation on equity shares for the 2025-26 financial year. (Source: Key Developments)
- At the May 26, 2026 board meeting, Sumitomo Chemical India declared a dividend of ₹1.30 per equity share on 49,91,45,736 equity shares of ₹10 each for the financial year ended March 31, 2026, subject to shareholder approval at the AGM. (Source: Key Developments)
- Sumitomo Chemical India announced an annual dividend of ₹1.30 per share, with an ex-date and record date set for July 17, 2026, for eligible shareholders. (Source: Key Developments)
Valuation Changes
- Fair Value: The fair value estimate for Sumitomo Chemical India is unchanged at ₹555.33 per share, indicating no revision to the central valuation outcome.
- Discount Rate: The discount rate has risen slightly from 12.64% to 12.67%, reflecting a very small adjustment to the cost of capital assumptions.
- Revenue Growth: The long term revenue growth assumption remains effectively stable at about 12.86%, with only a negligible technical adjustment in the underlying model.
- Net Profit Margin: The profit margin input is essentially unchanged at roughly 18.49%, suggesting no material shift in margin expectations used in the valuation.
- Future P/E: The future P/E multiple has risen slightly from 45.72x to 45.76x, a minimal change that does not materially alter the valuation narrative for Sumitomo Chemical India.
Key Takeaways
- Product launches and strategic campaigns are bolstering sales growth and market presence, positioning the company for future revenue expansion and improved margins.
- Strengthening export markets and increased agrochemical demand are expected to support revenue and earnings growth, aided by higher production capabilities and favorable agricultural conditions.
- Heavy reliance on domestic revenue and adverse weather conditions may impact revenue growth and pricing strategies, despite improved export sales.
Catalysts
About Sumitomo Chemical India- Engages in the manufacture and sale of household and public health insecticides, agricultural pesticides, and animal nutrition products in India and internationally.
- Introduction of new products like Meshi, Ormie, and Portion is driving significant year-over-year sales growth, suggesting future revenue expansion as these products gain market acceptance.
- Normalization of export markets, especially with significant increases in sales to Japan and South America, is rebounding revenues and should continue to support earnings growth.
- The environmental clearance for the Dahej plant and planned CapEx could scale production capabilities, facilitating higher future revenues and optimizing operational efficiencies.
- Campaigns like Every Day Farmer's Day, which engage directly with farmers, enhance product visibility and adoption, potentially driving long-term revenue growth and improving net margins through better brand positioning.
- Anticipations for higher agrochemical consumption due to increased crop acreage in the upcoming rabi season should positively impact revenues and earnings, supported by favorable monsoon conditions and ambitious governmental food grain production targets.
Sumitomo Chemical India Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Sumitomo Chemical India's revenue will grow by 12.9% annually over the next 3 years.
- Analysts assume that profit margins will increase from 16.8% today to 18.5% in 3 years time.
- Analysts expect earnings to reach ₹8.6 billion (and earnings per share of ₹17.25) by about June 2029, up from ₹5.4 billion today. The analysts are largely in agreement about this estimate.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 45.8x on those 2029 earnings, up from 40.0x today. This future PE is greater than the current PE for the IN Chemicals industry at 20.8x.
- Analysts expect the number of shares outstanding to decline by 0.15% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 12.67%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Excess rainfall disrupting crop protection activities in India has impacted the consumption of agrochemical products, which may adversely affect future revenue growth.
- A significant decline in cotton acreage, particularly in North India, may reduce demand for pesticides, potentially affecting Sumitomo Chemical India's revenue.
- Despite improved export sales, any future challenges in global markets or inventory overhangs could negatively impact export revenue growth.
- Increased competition and potentially unpredictable market dynamics may affect pricing strategies, potentially impacting net margins if cost savings and pricing power cannot be maintained.
- Heavy reliance on domestic agrochemical revenue (83% of overall revenues) poses a risk if there are contractions in the domestic market demand due to adverse weather conditions or crop shifts, impacting overall earnings.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of ₹555.33 for Sumitomo Chemical India based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of ₹600.0, and the most bearish reporting a price target of just ₹435.0.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be ₹46.6 billion, earnings will come to ₹8.6 billion, and it would be trading on a PE ratio of 45.8x, assuming you use a discount rate of 12.7%.
- Given the current share price of ₹435.3, the analyst price target of ₹555.33 is 21.6% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Sumitomo Chemical India?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
